BioMed Realty Acquisition of 2100 Pennsylvania Ave Flex Lab

Deal value: $61,000,000

BioMed Realty acquired a 98,000 SF flex lab/office building in San Diego, CA, with 70% lab buildout, targeting biotech and life science tenants.

BioMed Realty’s acquisition of the 2100 Pennsylvania Ave flex lab is driven by a conviction in the long-term growth and resilience of the life sciences sector, particularly in San Diego, a top biotech hub. Despite current elevated vacancies and subdued demand, BioMed is positioning itself to capture future upside as biotech R&D rebounds, especially in fields like oncology, diabetes, and dementia. The asset’s 70% lab buildout and location target high-value biotech tenants, aligning with BioMed’s strategy to concentrate holdings in core innovation markets.